What is it about?
Risk of neuropsychiatric events associated with leukotriene-receptor antagonist use differs between risk periods and age groups. Risk is increased 4–14 days after initiation of the medication in adolescents and young adults, but not in children.
Featured Image
Read the Original
This page is a summary of: Leukotriene receptor antagonists and risk of neuropsychiatric events in children, adolescents and young adults: a self-controlled case series, European Respiratory Journal, May 2022, European Respiratory Society (ERS),
DOI: 10.1183/13993003.02467-2021.
You can read the full text:
Contributors
The following have contributed to this page
